We are live on
!
Find out more
KCA
KVP Capital Advisors Portfolio holdings
AUM
$134M
This Fund
S&P 500
This Quarter
Est. Return
+33.24%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
+$37.1M
(+38%)
Cap. Flow
+$26M
Cap. Flow
% of AUM
19.42%
Top 10 Holdings %
Top 10 Hldgs %
61.06%
Holding
34
New
9
Increased
1
Reduced
–
Closed
2
Top Buys
| 1 |
Sutro Biopharma
STRO
|
+$4.09M |
| 2 |
Erasca
ERAS
|
+$4.02M |
| 3 |
Viridian Therapeutics
VRDN
|
+$3.71M |
| 4 |
Tango Therapeutics
TNGX
|
+$3.2M |
| 5 |
Compass Therapeutics
CMPX
|
+$2.89M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.98M |
| 2 |
Fulcrum Therapeutics
FULC
|
+$566K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLNO
26
DELISTED
Soleno Therapeutics
SLNO
| $2M | 1.49% |
59,700
| – | – |
|
27
Nektar Therapeutics
NKTR
$2.31B
| $1.94M | 1.45% |
26,900
| – | – |
|
28
Cabaletta Bio
CABA
$452M
| $1.36M | 1.02% |
505,431
| – | – |
|
29
Achieve Life Sciences
ACHV
$626M
| $1.36M | 1.02% |
462,355
| – | – |
|
30
Vera Therapeutics
VERA
$2.98B
| $1.32M | 0.98% |
32,700
| – | – |
|
31
Celcuity
CELC
$5.06B
| $457K | 0.34% |
4,000
| – | – |
|
32
VYNE Therapeutics
VYNE
$22M
| $299K | 0.22% |
500,551
| – | – |
|
|
33
Fulcrum Therapeutics
FULC
$236M
| – | – |
-50,000
| Closed | -$566K |
|
|
34
Jazz Pharmaceuticals
JAZZ
$14.9B
| – | – |
-17,500
| Closed | -$2.98M |
|
Similar funds
RA
BWM
LEP
RLWM
PTFIS
SWM
SA
HCA